tradingkey.logo

AxoGen Inc

AXGN
35.460USD
+0.440+1.26%
Trading geöffnet ETKurse um 15 Minuten verzögert
1.64BMarktkapitalisierung
VerlustKGV TTM

AxoGen Inc

35.460
+0.440+1.26%

mehr Informationen über AxoGen Inc Unternehmen

Axogen, Inc. is focused on the science, development, and commercialization of technologies for peripheral nerve regeneration and repair. It offers repair solutions for surgeons and healthcare providers. Its portfolio of products includes Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector, Axoguard HA+ Nerve Protector, Axoguard Nerve Cap, and Avive+ Soft Tissue Matrix. Avance Nerve Graft is a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves. The Axoguard Nerve Connector is a porcine (pig) submucosa extracellular matrix (ECM) coaptation aid for tensionless repair of severed peripheral nerves. Axoguard Nerve Protector is a porcine submucosa ECM product used to wrap and protect damaged peripheral nerves and reinforce the nerve reconstruction while preventing soft tissue attachments. Axoguard HA+ Nerve Protector consists of a processed porcine submucosa ECM base layer with a hyaluronate-alginate gel coating.

AxoGen Inc Informationen

BörsenkürzelAXGN
Name des UnternehmensAxoGen Inc
IPO-datumDec 17, 1986
CEODale (Michael Donald)
Anzahl der mitarbeiter451
WertpapierartOrdinary Share
GeschäftsjahresendeDec 17
Addresse13631 Progress Blvd.
StadtALACHUA
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl32615
Telefon13864626817
Websitehttps://www.axogeninc.com/
BörsenkürzelAXGN
IPO-datumDec 17, 1986
CEODale (Michael Donald)

Führungskräfte von AxoGen Inc

Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
31.38K
+10613.00%
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
27.03K
+14344.00%
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
--
--
Ms. Amy A. Mcbride-Wendell
Ms. Amy A. Mcbride-Wendell
Lead Independent Director
Lead Independent Director
--
--
Mr. Alan M. Levine
Mr. Alan M. Levine
Independent Director
Independent Director
--
--
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
--
-21399.00%
Mr. John H. Johnson
Mr. John H. Johnson
Independent Director
Independent Director
--
--
Mr. William P. (Bill) Burke
Mr. William P. (Bill) Burke
Independent Director
Independent Director
--
--
Dr. Joseph (Adrian) Tyndall, M.D.
Dr. Joseph (Adrian) Tyndall, M.D.
Independent Director
Independent Director
--
--
Mr. Marc A. Began
Mr. Marc A. Began
Executive Vice President, Chief Compliance Officer, General Counsel
Executive Vice President, Chief Compliance Officer, General Counsel
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Ms. Lindsey Hartley
Ms. Lindsey Hartley
Chief Financial Officer
Chief Financial Officer
31.38K
+10613.00%
Mr. Jens Schroeder Kemp
Mr. Jens Schroeder Kemp
Chief Marketing Officer
Chief Marketing Officer
27.03K
+14344.00%
Mr. Erick Wayne Devinney
Mr. Erick Wayne Devinney
Chief Innovation Officer
Chief Innovation Officer
--
--
Ms. Amy A. Mcbride-Wendell
Ms. Amy A. Mcbride-Wendell
Lead Independent Director
Lead Independent Director
--
--
Mr. Alan M. Levine
Mr. Alan M. Levine
Independent Director
Independent Director
--
--
Mr. Paul G. Thomas
Mr. Paul G. Thomas
Independent Chairman of the Board
Independent Chairman of the Board
--
-21399.00%

Umsatzaufteilung

FY2023
FY2022
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.
Nach RegionUSD
Name
Umsatz
Anteil
United States
159.01M
0.00%
Nach Geschäftsbereich
Nach Region
Relevante Daten wurden vom Unternehmen noch nicht offengelegt.

Aktionärsstatistik

Aktualisiert: Fri, Jan 2
Aktualisiert: Fri, Jan 2
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
First Light Asset Management, LLC
11.58%
BlackRock Institutional Trust Company, N.A.
6.34%
The Vanguard Group, Inc.
5.70%
Morgan Stanley & Co. LLC
4.56%
ArrowMark Colorado Holdings, LLC
3.91%
Andere
67.90%
Aktionäre
Aktionäre
Anteil
First Light Asset Management, LLC
11.58%
BlackRock Institutional Trust Company, N.A.
6.34%
The Vanguard Group, Inc.
5.70%
Morgan Stanley & Co. LLC
4.56%
ArrowMark Colorado Holdings, LLC
3.91%
Andere
67.90%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
37.23%
Investment Advisor
27.86%
Hedge Fund
13.23%
Research Firm
5.95%
Individual Investor
2.50%
Family Office
1.62%
Bank and Trust
0.41%
Pension Fund
0.30%
Sovereign Wealth Fund
0.12%
Andere
10.77%

Institutionelle Beteiligung

Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
342
42.08M
97.83%
+8.74K
2025Q3
350
42.06M
101.71%
+627.35K
2025Q2
344
41.40M
98.61%
+1.26M
2025Q1
339
40.15M
93.21%
-2.27M
2024Q4
327
37.35M
99.16%
-1.08M
2024Q3
305
37.98M
92.55%
+3.00M
2024Q2
285
37.71M
96.69%
+1.44M
2024Q1
290
36.54M
95.40%
-4.68M
2023Q4
299
34.97M
92.73%
+437.14K
2023Q3
304
34.60M
92.75%
-2.09M
Mehr Anzeigen

Aktionärsaktivitäten

Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
First Light Asset Management, LLC
5.81M
12.59%
+1.28M
+28.18%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.18M
6.89%
+76.53K
+2.47%
Sep 30, 2025
The Vanguard Group, Inc.
2.67M
5.79%
-51.00K
-1.87%
Sep 30, 2025
Morgan Stanley & Co. LLC
2.29M
4.96%
+352.54K
+18.22%
Sep 30, 2025
ArrowMark Colorado Holdings, LLC
1.96M
4.25%
+332.50K
+20.45%
Sep 30, 2025
Soleus Capital Management, L.P.
1.73M
3.74%
+267.16K
+18.31%
Sep 30, 2025
Wasatch Global Investors Inc
1.64M
3.55%
+205.57K
+14.34%
Sep 30, 2025
Assenagon Asset Management S.A.
1.29M
2.79%
+265.95K
+25.99%
Sep 30, 2025
Balyasny Asset Management LP
1.38M
2.99%
-551.52K
-28.56%
Sep 30, 2025
Armistice Capital LLC
1.20M
2.6%
+88.68K
+7.98%
Sep 30, 2025
Mehr Anzeigen

Verbundene ETFs

Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
ROBO Global Healthcare Technology & Innovation ETF
3.51%
State Street SPDR S&P Health Care Equipment ETF
2.3%
iShares Neuroscience and Healthcare ETF
2.11%
Invesco Dorsey Wright Healthcare Momentum ETF
0.97%
Invesco NASDAQ Future Gen 200 ETF
0.74%
JPMorgan Fundamental Data Science Small Core ETF
0.21%
iShares Micro-Cap ETF
0.19%
Fidelity Enhanced Small Cap ETF
0.18%
Principal U.S. Small-Cap ETF
0.15%
Franklin US Small Cap Multifactor Index ETF
0.14%
Mehr Anzeigen
ROBO Global Healthcare Technology & Innovation ETF
Anteil3.51%
State Street SPDR S&P Health Care Equipment ETF
Anteil2.3%
iShares Neuroscience and Healthcare ETF
Anteil2.11%
Invesco Dorsey Wright Healthcare Momentum ETF
Anteil0.97%
Invesco NASDAQ Future Gen 200 ETF
Anteil0.74%
JPMorgan Fundamental Data Science Small Core ETF
Anteil0.21%
iShares Micro-Cap ETF
Anteil0.19%
Fidelity Enhanced Small Cap ETF
Anteil0.18%
Principal U.S. Small-Cap ETF
Anteil0.15%
Franklin US Small Cap Multifactor Index ETF
Anteil0.14%

Dividende

In den vergangenen 5 Jahren wurden insgesamt 0.00 USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten

Aktien-Split

Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
KeyAI